Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Critical Issues in Head and Neck Oncology : Key Concepts from the Eighth THNO Meeting / / edited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O'Sullivan
| Critical Issues in Head and Neck Oncology : Key Concepts from the Eighth THNO Meeting / / edited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O'Sullivan |
| Autore | Vermorken Jan B |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (ix, 365 pages) : illustrations (some color) |
| Disciplina | 616.994 |
| Soggetto topico |
Oncology
Radiology Cancer - Treatment Cancer Therapy |
| ISBN | 3-031-23175-9 |
| Classificazione | MED008000MED062000 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | The gut microbiota and anticancer immunotherapy, Laurence Zitvogel -- The bidirectional communication between tumor cells and other components of the tumor microenvironment, Phil Sloan -- Resistance mechanisms in immune checkpoint inhibitors and radiotherapy and how to overcome this, Kirsten Lauber -- DNA repair mechanisms as a new target in head and neck cancer, Kevin Harrington -- How to standardize molecular profiling programs for routine patient care, Ingeborg Tinhofer -- Novel immune oncology targets beyond PD-1/PD-L1 in head and neck cancer, Christophe Le Tourneau -- Analytic methods to understand head and neck cancer evolution to guide therapeutic approaches, Ben O’Leary -- Clinical cases, Jean Pascal Machiels -- Updates from the European Head & Neck Society (EHNS), Wojciech Golusinski (President of EHNS) Section 2: Primary disease Piero Nicolai -- Sensitivity and specificity of extranodal extension in SCCHN: unlocking the strongest prognostic factor in head and neckcancer, Brian O’Sullivan -- From photon to proton: what’s in it for head and neck cancer patients?, Volker Budach -- Lessons learned from RTOG 1016 and DE-ESCALaTE: what’s next?, Hisham Mehanna.-Treatment intensification in LA-SCCHN: what are the options and for who?, Jan Vermorken -- Immune checkpoint inhibitors in the curative setting: preclinical and clinical data, Jean-Pascal Machiels -- Carcinoma of unknown primary: diagnostics and the potential of transoral surgery, René Leemans -- Clinical cases, Volker Budach -- Individualized therapy in 1-line R/M-SCCHN: what selection criteria should we use?, Petr Szturz -- Patterns of response to immune oncology drugs: how relevant are they in SCCHN?, Amanda Psyrri -- The role of radiotherapy in oligometastatic or oligoprogressive disease in R/M-SCCHN, Daan Nevens -- Updates from the EORTC Head and Neck Cancer Group (HNCG), Jean-Pascal Machiels (Chair of EORTC-HNCG) -- Real world evidence in head and neck cancer, Anil D’Cruz (UICC president -- Pathology driven treatment of skull base tumors, Piero Nicolai -- Modern day reconstruction of facial bones, Sat Parmar -- Targeting molecular/minimal residual disease using novel technologies and clinical trials design, Lillian Siu -- New developments in surgery for malignant salivary gland tumors, Jeroen Meulemans -- New systemic therapies in salivary gland cancer, Ethan Argiris. Exercise and nutrition interventions in head and neck cancer, Paolo Bossi -- Telehealth intervention in head and neck cancer patients: a promise?, Irma Verdonck-de Leeuw. |
| Record Nr. | UNINA-9910682530203321 |
Vermorken Jan B
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Critical Issues in Head and Neck Oncology : Key Concepts from the Seventh THNO Meeting / / edited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O’Sullivan
| Critical Issues in Head and Neck Oncology : Key Concepts from the Seventh THNO Meeting / / edited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O’Sullivan |
| Autore | Vermorken Jan B |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021 |
| Descrizione fisica | 1 online resource (IX, 373 p. 39 illus., 33 illus. in color.) |
| Disciplina | 616.994 |
| Collana | Medicine Series |
| Soggetto topico |
Oncology
Radiology Cancer - Treatment Cancer Therapy |
| ISBN | 3-030-63234-2 |
| Classificazione | MED062000MED080000MED085000 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) -- Promising biomarkers for early diagnosis and prognosis prediction in HNS -- Biomarkers to predict radiotherapy toxicity -- Biomarkers for hypoxia, HPVness and proliferation from imaging perspective -- Mechanism of cetuximab resistance and how to overcome it -- The role of liquid biopsy for monitoring disease evolution -- NK cells in immunotherapy: how important are they? -- Biomarkers for immune modulatory treatment in HNSCC -- Primary disease (1) -- Novel approaches in surgical management of HNSCC -- The surgical approach to elderly patients with HNSCC -- The nonsurgical approach to locoregionally advanced HNSCC -- High-dose three-weekly or low-dose weekly cisplatin during radiation, what to prefer? -- Primary disease (2) -- Where and when to use induction chemotherapy? -- Prognostic role of p16/HPV in non-oropharyngeal head and neck cancer -- Is there a role for neoadjuvant targeted and immunotherapies? -- Is there a role for adjuvant targeted and immunotherapies? -- Optimal supportive measures during primary treatment -- Precision Medicine in head and neck cancer: myth or reality -- Recurrent and / or metastatic disease -- Salvage surgery: candidates, safe reconstruction, and results? -- Re-irradiation for local relapses or second primaries: when and how? -- New promising targeted agents in first and second-line settings -- Update of immune therapies in recurrent/metastatic HNSCC -- Special Issue -- Patients with rare head neck cancers: do they need a different approach? .-Nasopharynx cancer -- New epidemiological aspects -- New developments in the management of nasopharyngeal carcinoma -- New drugs for recurrent/metastatic nasopharynx cancer. |
| Record Nr. | UNINA-9910484360603321 |
|
Vermorken Jan B
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Critical Issues in Head and Neck Oncology : Key Concepts from the Ninth THNO Meeting / / edited by Jan B. Vermorken, Johannes A. Langendijk, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O'Sullivan
| Critical Issues in Head and Neck Oncology : Key Concepts from the Ninth THNO Meeting / / edited by Jan B. Vermorken, Johannes A. Langendijk, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O'Sullivan |
| Edizione | [1st ed. 2025.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025 |
| Descrizione fisica | 1 online resource (IX, 399 p. 56 illus., 55 illus. in color.) |
| Disciplina | 616.994 |
| Soggetto topico |
Oncology
Radiology Cancer - Treatment Cancer Therapy |
| ISBN | 3-031-84539-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section 1: From basic science to clinical application -- 1. Oral potentially malignant disorders (OPMD): an update, Ruud Brakenhoff -- 2. The role of artificial intelligence in OPMD -- 3. Treatment of OPMD and first results of immune checkpoint inhibitors -- 4. Innovations in cell-based assays for drug discovery and drug evaluation -- 5. Is the ESCAT ranking of support in head and neck cancer management? -- 6. Mechanism of action and potential use of SMAC mimetics in HNSCC -- 7. Precision medicine beyond genomics -- Section 2: Primary disease -- 8. Sentinel Node Biopsy in cN0 Early-Stage Oral Cavity Cancer: what is the evidence? -- 9. Partial laryngeal surgery in 2023 -- 10. Managing the internal carotid artery in head and neck cancer: where are we? -- 11. Improving quality of reconstructive surgery in head and neck cancer -- 12. Innovation in radiotherapy: “FLASH-therapy” -- 13. Hypoxia in head and neck cancer: current relevance -- 14. Hyperthermia: a game changer in the management of head and neck cancer? -- Section 3: Primary disease -- 15. Prognostic factors in HPV-positive oropharyngeal cancer: an update -- 16. Immunotherapy and novel agents in locoregionally advanced HNSCC -- 17. Is reducing the extent of local treatments justified after successful neoadjuvant therapy? -- 18. Noninvasive biomarkers predicting outcome in patients with locoregionally advanced HNSCC -- 19. Innovations in head and neck surgery in the 21st century -- 20. Impact of emerging technology developments in proton therapy -- Section 4: Recurrent/Metastatic (R/M) disease -- 21. 50 years of systemic therapy: what have we gained? -- 22. The potential roles of Antibody-Drug Conjugates in head and neck cancer -- 23. Intratumoral drug administration: more potential in head and neck cancer? -- 24. Novel radioenhancer NBTXR3 as a single agent in locally advanced (LA) HNSCC or in combination with anti-PD1 in R/M HNSCC -- 25. Metronomic chemotherapy and immunotherapy: a fascinating approach -- 26. Metastatic head and neck cancer: what is the optimal local treatment? -- Section 5: Salivary Gland cancer -- 27. Molecular characterization of salivary gland cancer and treatment implications -- 28. Salivary duct carcinoma: strategies to improve outcome. |
| Record Nr. | UNINA-9911003578103321 |
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Critical Issues in Head and Neck Oncology : Key Concepts from the Sixth THNO Meeting / / edited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O'Sullivan
| Critical Issues in Head and Neck Oncology : Key Concepts from the Sixth THNO Meeting / / edited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O'Sullivan |
| Edizione | [1st ed. 2018.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 |
| Descrizione fisica | 1 online resource (425 pages) |
| Disciplina | 616.99491 |
| Soggetto topico |
Oncology
Radiotherapy Cancer - Research Cancer Research |
| ISBN | 3-319-98854-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I. Epidemiology and diagnosis -- The role of vaccination in head and neck cancer prevention -- Cellular and molecular pathology in head and neck cancer -- Part II. Prediction of outcome -- Oncogenomics/proteomics of head and neck cancer -- Targeted next-generation sequencing in head and neck cancer -- Homologous recombination function as predictor of treatment response -- Part III. Oral cavity cancer -- Surgical management of oral cavity cancer -- Reconstruction in oral cavity cancer: when and how -- Induction chemotherapy: does it have a place in oral cavity cancer? -- Are there alternative local treatments in oral cavity cancer? -- Part IV. Oropharynx cancer -- HPV assessment in oropharynx cancer: what is the gold standard? -- A new staging system for oropharynx cancer and why? -- Should we de-escalate the treatment in HPV-positive oropharynx cancer? -- Is there a new role for surgery in oropharynx cancer? -- Can we expect less toxicity with newer forms of radiation? -- Part V. Miscellaneous topics -- What is the optimal larynx preservation approach and who are the candidates? -- Is the approach to patients with unknown primary tumors any different in 2017? -- Cytotoxic chemotherapy and targeted therapy in nasopharynx cancer -- Are there alternative chemotherapy regimens for EXTREME in recurrent/metastatic SCCHN -- New data on systemic therapy of salivary gland tumors -- Treatment of elderly patients with head and neck cancer -- Part VI. Thyroid cancer -- World-wide thyroid cancer epidemics: what is going on? -- The surgical approach to thyroid cancer in 2017 -- Part VII. Keynote address -- Immunology and immunotherapy in head and neck cancer -- . |
| Record Nr. | UNINA-9910300305903321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Critical Issues in Head and Neck Oncology : Key concepts from the Fifth THNO Meeting / / edited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O'Sullivan
| Critical Issues in Head and Neck Oncology : Key concepts from the Fifth THNO Meeting / / edited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O'Sullivan |
| Edizione | [1st ed. 2017.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 |
| Descrizione fisica | 1 online resource (XIII, 296 p. 75 illus., 61 illus. in color.) |
| Disciplina | 616.994 |
| Soggetto topico | Oncology |
| ISBN | 3-319-42909-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section I : The Make Sense Campaign -- The Make Sense Campaign -- Section II: Head and Neck Cancer: a changing disease -- New epidemiologic aspects -- Biology of head and neck cancer -- Section III: Diagnostic challenges -- The changing role of the pathologist -- Molecular imaging in head and neck cancer -- Multidisciplinary Decision Making & Head and Neck Tumor Boards -- Clinical decision making: how and when. Section V: Locoregionally Advanced Head and Neck Cancer -- Pros and cons of endoscopic surgery -- Oncologic dentistry and implants -- Primary radiotherapy & concurrent chemoradiotherapy -- Treatment of viral-associated head and neck cancer -- Patient and treatment factors in concurrent chemoradiotherapy -- Section VI: Recurrent/Metastatic Head and Neck cancer: How and When to Treat -- The surgical approach -- When and how to irradiate -- Cytotoxic chemotherapy and targeted therapy -- Immunotherapeutic approaches -- Treatment in the elderly -- Supportive care -- Section VII -- Quality of life issues -- Palliative care in the palliative disease setting -- Community palliative care and dying at home. |
| Record Nr. | UNINA-9910155306003321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||